Which has the lower trailing P/E, AZN or TMO?

AZN has the lower trailing P/E: AZN trades at 24.05 and TMO at 32.80. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, AZN or TMO?

Over the past five years, AZN grew revenue faster — AZN at a 15.76% CAGR versus TMO at 5.00%.

Does AZN or TMO pay a bigger dividend?

AZN yields 2.02% and TMO yields 0.30% based on trailing dividends and the latest price.

Is AZN or TMO more profitable?

AZN runs the higher net margin — AZN at 17.02% versus TMO at 15.06%.

How have AZN and TMO total returns compared?

Over the past 10 years, AZN delivered 12.85% and TMO delivered 15.81% annualized total return. Past performance doesn't predict future results.

AstraZeneca PLC (AZN) vs Thermo Fisher Scientific Inc. (TMO)

A side-by-side comparison of AstraZeneca PLC and Thermo Fisher Scientific Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of September 10, 2026. Differences are shown without an overall score or investment verdict.

AZN

AstraZeneca PLC

$248.40B

$160.17HealthcareDelayed quote: Sep 11, 2026, 4:00 PM EDT

TMO

Thermo Fisher Scientific Inc.

$226.62B

$609.82HealthcareDelayed quote: Sep 11, 2026, 4:00 PM EDT

Total return — AZN vs TMO

growth of $100 · dividends reinvested · last 10y

AZN +234.4% (+12.8%/yr)TMO +314.9% (+15.3%/yr)TMO compounded faster over this window

AZN TMO

AZN vs TMO: by the numbers

•AZN is the larger company ($248.40B vs $226.62B market cap).
•AZN trades at the lower trailing earnings multiple (24.05 vs 32.80 P/E), one valuation lens rather than an overall verdict.
•AZN converts more revenue to profit (17.02% vs 15.06% net margin).
•AZN grew revenue faster over the past five years (15.76% vs 5.00% CAGR).
•AZN pays the higher dividend yield (2.02% vs 0.30%).

Metrics side by side

Valuation

Metric	AZN	TMO
P/E ratio	24.05	32.80
Forward P/E	15.64	24.29
P/S ratio	4.05	4.89
P/B ratio	4.94	4.30
EV / EBITDA	13.56	25.25
FCF yield	3.52%	3.23%

Profitability

Metric	AZN	TMO
Gross margin	81.88%	40.37%
Operating margin	22.77%	17.69%
Net margin	17.02%	15.06%
ROE	20.79%	13.25%
ROIC	12.83%	7.44%

Dividends

Metric	AZN	TMO
Dividend yield	2.02%	0.30%
Payout ratio	48.50%	9.68%

Growth (annualized)

Metric	AZN	TMO
Revenue CAGR (5Y)	15.76%	5.00%
EPS CAGR (5Y)	22.02%	1.99%
FCF CAGR (5Y)	14.53%	-1.83%
Total return CAGR (5Y)	9.46%	1.55%

Frequently asked

Which has the lower trailing P/E, AZN or TMO?: AZN has the lower trailing P/E: AZN trades at 24.05 and TMO at 32.80. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, AZN or TMO?: Over the past five years, AZN grew revenue faster — AZN at a 15.76% CAGR versus TMO at 5.00%.
Does AZN or TMO pay a bigger dividend?: AZN yields 2.02% and TMO yields 0.30% based on trailing dividends and the latest price.
Is AZN or TMO more profitable?: AZN runs the higher net margin — AZN at 17.02% versus TMO at 15.06%.
How have AZN and TMO total returns compared?: Over the past 10 years, AZN delivered 12.85% and TMO delivered 15.81% annualized total return. Past performance doesn't predict future results.

Go deeper

Full AZN analysis Full TMO analysis Interactive comparison tool

Dig into the metrics

AstraZeneca P/E ratio Thermo Fisher Scientific P/E ratio AstraZeneca dividend yield Thermo Fisher Scientific dividend yield AstraZeneca ROE Thermo Fisher Scientific ROE AstraZeneca operating margin Thermo Fisher Scientific operating margin AstraZeneca revenue growth Thermo Fisher Scientific revenue growth AstraZeneca free cash flow Thermo Fisher Scientific free cash flow

AstraZeneca & Thermo Fisher Scientific appear in these rankings

Highest Dividend Yield Stocks Fastest Revenue Growth Stocks Highest 10-Year Total Return Stocks Largest Companies by Market Cap

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified September 10, 2026.